Alembic Pharmaceuticals

quarterly
yearly
ParticularsSep '21Dec '21Mar '22Jun '22Sep '22
Revenue1,2921,2721,4161,2621,475
Expenses1,0901,0721,4131,3151,310
EBITDA202.62199.712.27-52.45165.04
EBIT148.02143.77-120.82-119.5597.34
Profit Before Tax200.24196.7340.60-60.16152.96
Net Profit169.29176.4210.71-65.88133.35
Financial Ratios
Operating Profit Margin15.68%15.70%0.16%-4.16%11.19%
Net Profit Margin13.10%13.87%0.76%-5.22%9.04%
Earning Per Share (Diluted)8.618.980.54-3.356.78
Dividends Per ShareNANA10.00NANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.5.6
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI